Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Creative Medical Technology | CELZ | Mar 14, 2025 | 3.27 | +9.00 |
Creative Realities | CREX | Mar 14, 2025 | 1.88 | +3.30 |
Credicorp | BAP | Mar 14, 2025 | 189.39 | +2.33 |
Credit Acceptance | CACC | Mar 14, 2025 | 478.21 | +4.28 |
Credit Enhanced Corts Trust Aon Capital A | KTN | Mar 14, 2025 | 26.40 | 0.00 |
Credit Suisse Ag | SLVO | Mar 14, 2025 | 82.61 | +0.02 |
Credit Suisse Ag | GLDI | Mar 14, 2025 | 160.03 | +0.17 |
Credit Suisse Asset Management Income Fund | CIK | Mar 14, 2025 | 2.90 | +0.35 |
Credit Suisse Gold Shares Covered Calls ETN | USOI | Mar 14, 2025 | 58.97 | +0.87 |
Credit Suisse High Yield Bond Fund | DHY | Mar 14, 2025 | 2.14 | +1.33 |
Credo Technology | CRDO | Mar 14, 2025 | 49.15 | +9.34 |
Crescent Capital BDC | CCAP | Mar 14, 2025 | 17.12 | +1.78 |
Crescent Energy | CRGY | Mar 14, 2025 | 10.91 | +4.00 |
Cresud A ADR | CRESY | Mar 14, 2025 | 10.83 | +3.93 |
Crexendo | CXDO | Mar 14, 2025 | 5.75 | -6.66 |
CRH | CRH | Mar 14, 2025 | 97.02 | +2.56 |
Cricut A | CRCT | Mar 14, 2025 | 5.38 | +3.46 |
Crinetics Pharmaceuticals | CRNX | Mar 14, 2025 | 34.47 | -1.63 |
CRISPR Therapeutics | CRSP | Mar 14, 2025 | 42.12 | +0.31 |
Criteo ADR | CRTO | Mar 14, 2025 | 36.23 | +4.08 |
Critical Metals | CRML | Mar 14, 2025 | 1.98 | -7.48 |
Crocs | CROX | Mar 14, 2025 | 98.60 | -1.40 |
Cronos Group | CRON | Mar 14, 2025 | 1.89 | +1.61 |
Cross Country Healthcare | CCRN | Mar 14, 2025 | 15.58 | -1.14 |
Cross Timbers Royalty Royalty Trust | CRT | Mar 14, 2025 | 10.93 | +1.67 |
CrossAmerica Partners LP Unit | CAPL | Mar 14, 2025 | 23.46 | +0.17 |
CrossFirst Bankshares | CFB | Mar 14, 2025 | 15.99 | 0.00 |
CrowdStrike A | CRWD | Mar 14, 2025 | 353.74 | +6.38 |
Crown Castle | CCI | Mar 14, 2025 | 103.22 | +8.55 |
Crown Crafts | CRWS | Mar 14, 2025 | 3.83 | -1.24 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.